Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PHATHOM PHARMACEUTICALS, INC.

(PHAT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Health Care Stocks Slide Wednesday as Biotechs Weigh on Sector

10/27/2021 | 03:56pm EST


ę MT Newswires 2021
All news about PHATHOM PHARMACEUTICALS, INC.
11/23Phathom Pharmaceuticals to Participate in the 4th Annual Evercore ISI HealthCONx Confer..
AQ
11/12Phathom Pharmaceuticals to Participate in Two Upcoming Investor Healthcare Conferences
GL
11/08Phathom Pharmaceuticals Narrows Q3 Net Loss Per Share
MT
11/08PHATHOM PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condit..
AQ
11/08Phathom Pharmaceuticals Reports Third Quarter 2021 Results and Provides Key Clinical, R..
PU
11/08Phathom Pharmaceuticals Reports Third Quarter 2021 Results and Provides Key Clinical, R..
AQ
11/08Earnings Flash (PHAT) PHATHOM PHARMACEUTICALS Posts Q3 Loss $-0.98
MT
11/08Phathom Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine M..
CI
10/27Phathom Pharmaceuticals Withdraws Public Offering
GL
10/27Health Care Stocks Slide Wednesday as Biotechs Weigh on Sector
MT
More news
Analyst Recommendations on PHATHOM PHARMACEUTICALS, INC.
More recommendations
Financials (USD)
Sales 2021 - - -
Net income 2021 -143 M - -
Net cash 2021 127 M - -
P/E ratio 2021 -4,63x
Yield 2021 -
Capitalization 543 M 543 M -
EV / Sales 2021 -
EV / Sales 2022 70,6x
Nbr of Employees 55
Free-Float 81,7%
Chart PHATHOM PHARMACEUTICALS, INC.
Duration : Period :
Phathom Pharmaceuticals, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PHATHOM PHARMACEUTICALS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 17,94 $
Average target price 57,40 $
Spread / Average Target 220%
EPS Revisions
Managers and Directors
Terrie Curran President, Chief Executive Officer & Director
Anthony J. Guzzo VP, Chief Financial & Accounting Officer
Eckhard S. D. Leifke Chief Medical Officer
Azmi Nabulsi Chief Operating Officer
Joseph Hand Chief Administrative Officer
Sector and Competitors
1st jan.Capi. (M$)
PHATHOM PHARMACEUTICALS, INC.-43.59%567
MODERNA, INC.252.74%149 412
LONZA GROUP AG28.41%58 671
IQVIA HOLDINGS INC.48.85%50 948
SEAGEN INC.-5.61%30 228
CELLTRION, INC.-42.34%24 321